These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9667973)

  • 1. Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells.
    Mekouar K; Mouscadet JF; Desmaële D; Subra F; Leh H; Savouré D; Auclair C; d'Angelo J
    J Med Chem; 1998 Jul; 41(15):2846-57. PubMed ID: 9667973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity.
    Normand-Bayle M; Bénard C; Zouhiri F; Mouscadet JF; Leh H; Thomas CM; Mbemba G; Desmaële D; d'Angelo J
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4019-22. PubMed ID: 16002283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
    Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM
    Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors.
    Li X; Vince R
    Bioorg Med Chem; 2006 Aug; 14(16):5742-55. PubMed ID: 16753300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
    Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
    J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.
    Artico M; Di Santo R; Costi R; Novellino E; Greco G; Massa S; Tramontano E; Marongiu ME; De Montis A; La Colla P
    J Med Chem; 1998 Oct; 41(21):3948-60. PubMed ID: 9767632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture.
    Zouhiri F; Mouscadet JF; Mekouar K; Desmaële D; Savouré D; Leh H; Subra F; Le Bret M; Auclair C; d'Angelo J
    J Med Chem; 2000 Apr; 43(8):1533-40. PubMed ID: 10780910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
    King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
    J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays.
    Costi R; Di Santo R; Artico M; Roux A; Ragno R; Massa S; Tramontano E; La Colla M; Loddo R; Marongiu ME; Pani A; La Colla P
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1745-9. PubMed ID: 15026063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: implication for binding to two metal ions on the active site of integrase.
    Long YQ; Jiang XH; Dayam R; Sanchez T; Shoemaker R; Sei S; Neamati N
    J Med Chem; 2004 May; 47(10):2561-73. PubMed ID: 15115398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines.
    Brzozowski Z; Saczewski F; Sanchez T; Kuo CL; Gdaniec M; Neamati N
    Bioorg Med Chem; 2004 Jul; 12(13):3663-72. PubMed ID: 15186851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors.
    Langford HM; Williams PD; Homnick CF; Vacca JP; Felock PJ; Stillmock KA; Witmer MV; Hazuda DJ; Gabryelski LJ; Schleif WA
    Bioorg Med Chem Lett; 2008 Jan; 18(2):721-5. PubMed ID: 18078751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrazide-containing inhibitors of HIV-1 integrase.
    Zhao H; Neamati N; Sunder S; Hong H; Wang S; Milne GW; Pommier Y; Burke TR
    J Med Chem; 1997 Mar; 40(6):937-41. PubMed ID: 9083482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro.
    Deprez E; Barbe S; Kolaski M; Leh H; Zouhiri F; Auclair C; Brochon JC; Le Bret M; Mouscadet JF
    Mol Pharmacol; 2004 Jan; 65(1):85-98. PubMed ID: 14722240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase.
    Du L; Zhao YX; Yang LM; Zheng YT; Tang Y; Shen X; Jiang HL
    Acta Pharmacol Sin; 2008 Oct; 29(10):1261-7. PubMed ID: 18817633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
    Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
    Verschueren WG; Dierynck I; Amssoms KI; Hu L; Boonants PM; Pille GM; Daeyaert FF; Hertogs K; Surleraux DL; Wigerinck PB
    J Med Chem; 2005 Mar; 48(6):1930-40. PubMed ID: 15771437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chicoric acid analogues as HIV-1 integrase inhibitors.
    Lin Z; Neamati N; Zhao H; Kiryu Y; Turpin JA; Aberham C; Strebel K; Kohn K; Witvrouw M; Pannecouque C; Debyser Z; De Clercq E; Rice WG; Pommier Y; Burke TR
    J Med Chem; 1999 Apr; 42(8):1401-14. PubMed ID: 10212126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
    Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.